Immunological diagnosis tests
Pre-clinicalTerminated 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Complement Deficiency
Conditions
Complement Deficiency, Antibody Deficiency, Chronic Sinus Infection, Meningitis, Bacterial, Pneumonia, Bacterial, Otitis Media, Streptococcal Infection, Neisseria Infections, Haemophilus Influenza, Pneumococcal Infections
Trial Timeline
Mar 1, 2015 → Mar 1, 2020
NCT ID
NCT02972281About Immunological diagnosis tests
Immunological diagnosis tests is a pre-clinical stage product being developed by CSL for Complement Deficiency. The current trial status is terminated. This product is registered under clinical trial identifier NCT02972281. Target conditions include Complement Deficiency, Antibody Deficiency, Chronic Sinus Infection.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02972281 | Pre-clinical | Terminated |
Competing Products
5 competing products in Complement Deficiency
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| CSL040 + Placebo | CSL | Phase 1 | 32 |
| BCX9930 | BioCryst Pharmaceuticals | Phase 2 | 47 |
| RP-L102 | Rocket Pharmaceuticals | Phase 2 | 44 |
| RP-L102 | Rocket Pharmaceuticals | Phase 1 | 25 |
| RP-L102 | Rocket Pharmaceuticals | Phase 2 | 44 |